Vanta Bioscience Limited
BSE: VANTABIO.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dopesh Raja Mulakala
- Employees
- 48
- Headquarters
- Hyderabad, India
- IPO year
- 2017
- Market cap
- ₹110.8M
- Website
- http://www.vantabio.com
Loading VANTABIO…
Loading profile data…Frequently asked questions about VANTABIO
What does Vanta Bioscience Limited (VANTABIO.BO) do?
Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. Its services include Discovery Toxicology, Agro-Chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation and Batch Release Test. The company was founded on April 29, 2016 and is headquartered in Hyderabad, India.
Where does VANTABIO.BO trade?
Vanta Bioscience Limited (VANTABIO.BO) trades on the Bombay Stock Exchange.
What sector is VANTABIO.BO in?
Vanta Bioscience Limited (VANTABIO.BO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vanta Bioscience Limited?
Dopesh Raja Mulakala is the chief executive officer of Vanta Bioscience Limited (VANTABIO.BO).
Where is Vanta Bioscience Limited headquartered?
Vanta Bioscience Limited is headquartered in India.
Does VANTABIO.BO pay a dividend?
Vanta Bioscience Limited (VANTABIO.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VANTABIO.BO go public?
Vanta Bioscience Limited (VANTABIO.BO) completed its initial public offering in 2017.